08.17.17
Evonik's prices for its aliphatic diisocyanates and derivatives – known by the brand names VESTANAT® and VESTAGON® – are set to immediately increase by as much as 10 percent on a global basis, the company announced Thursday.
All existing contracts will be honored, according to Evonik.
In a press release, the company noted the price increase "has become unavoidable to compensate higher costs for personnel, maintenance, regulatory affairs and logistics."
All existing contracts will be honored, according to Evonik.
In a press release, the company noted the price increase "has become unavoidable to compensate higher costs for personnel, maintenance, regulatory affairs and logistics."
